Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

VYGR holding history

Voyager Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VYGR overviewAll 13F holders of VYGRFull Q2 2026 holdings

Shares (Q2 2026)
838,184
Value
$2.93M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VYGR by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026838,184$2.93M<0.1%−37,384−4.3%ReducedHolders
Q1 2026875,568$3.38M<0.1%−208,931−19.3%ReducedHolders
Q4 20251,084,499$4.26M<0.1%−198,657−15.5%ReducedHolders
Q3 20251,283,156$5.99M<0.1%−138,026−9.7%ReducedHolders
Q2 20251,421,182$4.42M<0.1%−75,102−5.0%ReducedHolders
Q1 20251,496,284$5.06M<0.1%+115,669+8.4%AddedHolders
Q4 20241,380,615$7.83M<0.1%+275,571+24.9%AddedHolders
Q3 20241,105,044$6.46M<0.1%+291,364+35.8%AddedHolders
Q2 2024813,680$6.44M<0.1%−291,875−26.4%ReducedHolders
Q1 20241,105,555$10.3M<0.1%+173,324+18.6%AddedHolders
Q4 2023932,231$7.87M<0.1%+153,291+19.7%AddedHolders
Q3 2023778,940$6.04M<0.1%+445,545+133.6%AddedHolders
Q2 2023333,395$3.82M<0.1%+103,548+45.1%AddedHolders
Q1 2023229,847$1.77M<0.1%+89,036+63.2%AddedHolders
Q4 2022140,811$859.0K<0.1%+46,788+49.8%AddedHolders
Q3 202294,023$556.0K<0.1%−16,403−14.9%ReducedHolders
Q2 2022110,426$652.0K<0.1%+79,166+253.3%AddedHolders
Q1 202231,260$238.0K<0.1%00.0%UnchangedHolders
Q4 202131,260$85.0K<0.1%−14,765−32.1%ReducedHolders
Q3 202146,025$121.0K<0.1%−6,295−12.0%ReducedHolders
Q2 202152,320$216.0K<0.1%−8,541−14.0%ReducedHolders
Q1 202160,861$287.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.